These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1946145)

  • 1. (-)-Norpseudoephedrine, but not (+/-)-amphetamine, prevents the increase in fluid intake associated with ethanol presentation in rats.
    Nencini P; Valeri P
    Pharmacol Res; 1991 Jul; 24(1):83-91. PubMed ID: 1946145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance does not develop to the suppressant effects of (-)-norpseudoephedrine on ingestive behavior in the rat.
    Nencini P; Fraioli S; Perrella D
    Pharmacol Biochem Behav; 1996 Feb; 53(2):297-301. PubMed ID: 8808135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environment-specific reinstatement of amphetamine-mediated hyperdipsia by morphine and (-)-norpseudoephedrine.
    Nencini P; Fraioli S
    Pharmacol Biochem Behav; 1994 Feb; 47(2):339-43. PubMed ID: 8146226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Norpseudoephedrine, a metabolite of cathinone with amphetamine-like stimulus properties, enhances the analgesic and rate decreasing effects of morphine, but inhibits its discriminative properties.
    Nencini P; Fraioli S; Pascucci T; Nucerito CV
    Behav Brain Res; 1998 Apr; 92(1):11-20. PubMed ID: 9588681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary modulation of the anorectic potency of amphetamine.
    Marks-Kaufman R; Kanarek RB
    Pharmacol Biochem Behav; 1990 Feb; 35(2):301-6. PubMed ID: 2320637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and environmental aspects of drinking stimulated by chronic exposure to amphetamine in rats.
    Camanni S; Nencini P
    Gen Pharmacol; 1994 Jan; 25(1):7-13. PubMed ID: 8026715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats.
    Hsieh YS; Chen PN; Yu CH; Chen CH; Tsai TT; Kuo DY
    Neurotoxicology; 2015 May; 48():131-41. PubMed ID: 25825358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nimodipine on drinking behavior measured in the runway: comparison and interaction with (+/-)-amphetamine.
    Nencini P; Graziani M; Grassi MC
    Drug Alcohol Depend; 1988 Oct; 22(1-2):9-14. PubMed ID: 3234237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of opioid mechanisms in the anorectic effects of stimulants: U50,488H enhances amphetamine inhibition of free feeding in rats.
    Nencini P; Valeri P
    Pharmacol Biochem Behav; 1994 May; 48(1):63-8. PubMed ID: 7913232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of phenylpropanolamine, d-amphetamine and d-norpseudoephedrine on open-field locomotion and food intake in the rat.
    Eisenberg MS; Maher TJ; Silverman HI
    Appetite; 1987 Aug; 9(1):31-7. PubMed ID: 3662492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylpropanolamine and amphetamine disrupt postprandial satiety in rats.
    Rosofsky M; Geary N
    Pharmacol Biochem Behav; 1989 Dec; 34(4):797-803. PubMed ID: 2623033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats.
    Fraioli S; Cioli I; Nencini P
    Behav Brain Res; 1997 Dec; 89(1-2):199-215. PubMed ID: 9475627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of dopamine D(1) and D(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine.
    Chen TY; Duh SL; Huang CC; Lin TB; Kuo DY
    J Biomed Sci; 2001; 8(6):462-6. PubMed ID: 11702009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anorexigenic agents on deprivation-induced fluid consumption by rats.
    Zabik JE; Johnson W; Maickel RP
    Neuropharmacology; 1984 Nov; 23(11):1339-42. PubMed ID: 6527738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskinesias possibly induced by norpseudoephedrine.
    Thiel A; Dressler D
    J Neurol; 1994 Jan; 241(3):167-9. PubMed ID: 8164019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural effects of cathinone, an amine obtained from Catha edulis Forsk.: comparisons with amphetamine, norpseudoephedrine, apomorphine and nomifensine.
    Zelger JL; Schorno HX; Carlini EA
    Bull Narc; 1980; 32(3):67-81. PubMed ID: 6911034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):99-109. PubMed ID: 16084549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of oxidative stress in disrupting the function of negative glucocorticoid response element in daily amphetamine-treated rats.
    Chu SC; Yu CH; Chen PN; Hsieh YS; Kuo DY
    Psychoneuroendocrinology; 2016 Sep; 71():1-11. PubMed ID: 27235634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression.
    Kuo DY
    Behav Brain Res; 2003 Dec; 147(1-2):149-55. PubMed ID: 14659580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.